Showing 1 - 6 results of 6 for search 'T.I. Pilipenko', query time: 0.01s Refine Results
  1. 1
    PROSTHETIC TOOTH STRUCTURES WITH METAL BASE: INDIVIDUAL APPROACH

    PROSTHETIC TOOTH STRUCTURES WITH METAL BASE: INDIVIDUAL APPROACH by T.I. Pilipenko

    Published 2018-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Neuroinflammation and сhemotherapy-induced peripheral neuropathy

    Neuroinflammation and сhemotherapy-induced peripheral neuropathy by P. I. Pilipenko, V. E. Voytsitsky, Yu. A. Dobresko

    Published 2022-04-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Electrophysiological aspects of mini-invasive trigeminal neuralgia management

    Electrophysiological aspects of mini-invasive trigeminal neuralgia management by A. S. Petrovskaya, Ye. G. Melidi, A. L. Krivoshapkin, P. I. Pilipenko, Al. L. Krivoshapkin

    Published 2008-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Prevalence of anticonvulsant-induced vitamin D deficiency

    Prevalence of anticonvulsant-induced vitamin D deficiency by E. A. Dontseva, P. I. Pilipenko, N. A. Shnayder, M. M. Petrova, R. F. Nasyrova

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury.

    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury. by Pavel I Pilipenko, Anna A Ivanova, Yulia V Kotsiubinskaya, Vera N Grigoryeva, Alexey Y Khrulev, Anatoly V Skorokhodov, Maxim M Gavrik, Nona N Mkrtchan, Marek Majdan, Peter Valkovic, Daria Rabarova, Suzanne Barker-Collo, Kelly Jones, Valery L Feigin

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

    A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury by Pavel I. Pilipenko, Anna A. Ivanova, Yulia V. Kotsiubinskaya, Vera N. Grigoryeva, Alexey Y. Khrulev, Anatoly V. Skorokhodov, Maxim M. Gavrik, Nona N. Mkrtchan, Marek Majdan, Peter Valkovic, Daria Rabarova, Suzanne Barker-Collo, Kelly Jones, Valery L. Feigin

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: